middle.news
AFT Pharmaceuticals Eyes $300M Revenue with Global Expansion and R&D Milestones
6:30am on Wednesday 24th of June, 2026 AEST
•
Healthcare
Read Story
AFT Pharmaceuticals Eyes $300M Revenue with Global Expansion and R&D Milestones
6:30am on Wednesday 24th of June, 2026 AEST
Key Points
FY26 revenue growth of 22% to NZD 254.7 million
Operating profit of NZD 24.4 million exceeds guidance
Sales now in 87 countries with strong international growth
R&D pipeline includes injectable iron Phase III trial
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AFT Pharmaceuticals (NZX:AFT)
OPEN ARTICLE